Overview
- 5 inspections across 5 sites are on record.
- 7 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-01-14.
At a glance
Inspections
5
Sites
5
Observations
7
Career since
May 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Aliri USA Inc. | 14 Jan 2021 | Human Drugs | |
| TOLMAR Inc. | 8 Mar 2017 | Human Drugs | |
| Actavis Laboratories UT, Inc. | 17 Jan 2014 | Human Drugs | View 483 → |
| Front Range Laboratories, Inc. | 30 Aug 2013 | Human Drugs | On file |
| Hospira Boulder, Inc. | 15 May 2013 | Human Drugs | On file |
Sites inspected
Aliri USA Inc.Colorado Springs, United States1 insp.
TOLMAR Inc.Fort Collins, United States1 insp.
Actavis Laboratories UT, Inc.Salt Lake City, United States1 insp.
Front Range Laboratories, Inc.Loveland, United States1 insp.
Hospira Boulder, Inc.Boulder, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Erika V Butler2 shared
Zachery L Miller2 shared
Theressa B Smith1 shared
Zachary A Bogorad1 shared
Edith M Gonzalez1 shared
Kimberley A Hoefen1 shared
Marie B Buen-Bigornia1 shared
Full investigator report
Get the verbatim findings behind Andrea S Heise's 7 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site